ATE342273T1 - Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase - Google Patents

Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase

Info

Publication number
ATE342273T1
ATE342273T1 AT03725369T AT03725369T ATE342273T1 AT E342273 T1 ATE342273 T1 AT E342273T1 AT 03725369 T AT03725369 T AT 03725369T AT 03725369 T AT03725369 T AT 03725369T AT E342273 T1 ATE342273 T1 AT E342273T1
Authority
AT
Austria
Prior art keywords
side chain
solid phase
peptide amides
chain attachment
producing peptide
Prior art date
Application number
AT03725369T
Other languages
English (en)
Inventor
David John Evans
Dean Steven Anthony Simpkin
Donald Alfred Wellings
Eric Atherton
Original Assignee
Avecia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0210183.0A external-priority patent/GB0210183D0/en
Priority claimed from GB0210184A external-priority patent/GB0210184D0/en
Priority claimed from GB0210185A external-priority patent/GB0210185D0/en
Application filed by Avecia Ltd filed Critical Avecia Ltd
Application granted granted Critical
Publication of ATE342273T1 publication Critical patent/ATE342273T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/003—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by transforming the C-terminal amino acid to amides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT03725369T 2002-05-03 2003-05-02 Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase ATE342273T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0210183.0A GB0210183D0 (en) 2002-05-03 2002-05-03 Process
GB0210184A GB0210184D0 (en) 2002-05-03 2002-05-03 Process
GB0210185A GB0210185D0 (en) 2002-05-03 2002-05-03 Process

Publications (1)

Publication Number Publication Date
ATE342273T1 true ATE342273T1 (de) 2006-11-15

Family

ID=29407323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03725369T ATE342273T1 (de) 2002-05-03 2003-05-02 Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase

Country Status (9)

Country Link
US (1) US7691968B2 (de)
EP (1) EP1504022B1 (de)
JP (1) JP2006501150A (de)
AT (1) ATE342273T1 (de)
AU (1) AU2003227907A1 (de)
CA (1) CA2484594C (de)
DE (1) DE60309019T2 (de)
MX (1) MXPA04010910A (de)
WO (1) WO2003093302A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME01063B (me) * 2004-04-08 2012-10-20 Millennium Pharm Inc Postupak za dobijanje eptifibatida i odgovarajućih intermedijernih jedinjenja
CA2560007A1 (en) * 2004-06-14 2005-12-22 Usv Limited Process for the preparation of peptides
US7897724B2 (en) * 2004-10-10 2011-03-01 Usv, Ltd. Solid phase Fmoc chemistry process to prepare peptides
EP1805203B1 (de) * 2004-10-19 2010-01-13 Lonza Ag Peptid-cyclisierung auf harz
ATE480561T1 (de) 2004-10-19 2010-09-15 Lonza Ag Verfahren zur festphasen-peptidsynthese
EP2119724A1 (de) * 2005-05-03 2009-11-18 Novetide Ltd. Festphaseverfahren zur Herstellung von Goserelin
CN1858060B (zh) * 2005-05-08 2010-09-29 周达明 固相多肽合成依非巴特的制备方法
NL2000126C2 (nl) * 2005-07-15 2008-01-29 Solvay Werkwijze voor de vervaardiging van eptifibatide.
JP2010505781A (ja) * 2006-10-05 2010-02-25 ロンザ ア−ゲ− ペプチド合成法
US8815807B2 (en) 2008-06-03 2014-08-26 President And Fellows Of Harvard College Peptides and peptide compositions having osteoinductive activity
WO2009150657A1 (en) * 2008-06-09 2009-12-17 Natco Pharma Limited Improved process for preparation of eptifibatide by fmoc solid phase synthesis
HUE034308T2 (en) 2013-03-21 2018-02-28 Sanofi Aventis Deutschland Preparation of hydantoin-containing peptide products
US10450343B2 (en) 2013-03-21 2019-10-22 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
GB201310921D0 (en) * 2013-06-19 2013-07-31 Chemical & Biopharmaceutical Lab Of Patras S A Peptide-resin conjugate and use thereof
GB201315335D0 (en) 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
CN107108696B (zh) * 2014-12-26 2021-01-15 深圳华大生命科学研究院 芋螺毒素肽κ-CPTx-btl05、其制备方法及应用
CN110498834A (zh) * 2018-05-16 2019-11-26 深圳翰宇药业股份有限公司 一种依替巴肽固相制备的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033940A (en) 1975-11-12 1977-07-05 Armour Pharmaceutical Company Cyclization of peptides
US5318899A (en) * 1989-06-16 1994-06-07 Cor Therapeutics, Inc. Platelet aggregation inhibitors
US5780595A (en) 1989-06-16 1998-07-14 Cor Therapeutics, Inc. Platelet aggregation inhibitors
GB9112825D0 (en) 1991-06-14 1991-07-31 Ici Plc Process for making peptides
US6008058A (en) 1993-06-18 1999-12-28 University Of Louisville Cyclic peptide mixtures via side chain or backbone attachment and solid phase synthesis
GB9313330D0 (en) 1993-06-28 1993-08-11 Fujisawa Pharmaceutical Co New compound and its preparation
WO2000026262A2 (en) * 1998-11-05 2000-05-11 Mitokor Functionalized polymeric substrates for binding molecular moieties
AU1401902A (en) * 2000-10-17 2002-04-29 Applied Research Systems Pharmaceutically active sulfanilide derivatives

Also Published As

Publication number Publication date
US7691968B2 (en) 2010-04-06
DE60309019T2 (de) 2007-05-16
WO2003093302A3 (en) 2004-01-08
DE60309019D1 (de) 2006-11-23
EP1504022B1 (de) 2006-10-11
JP2006501150A (ja) 2006-01-12
CA2484594C (en) 2012-06-26
MXPA04010910A (es) 2005-01-25
US20050266520A1 (en) 2005-12-01
WO2003093302A2 (en) 2003-11-13
AU2003227907A8 (en) 2003-11-17
CA2484594A1 (en) 2003-11-13
AU2003227907A1 (en) 2003-11-17
EP1504022A2 (de) 2005-02-09

Similar Documents

Publication Publication Date Title
DE60309019D1 (de) Verfahren zur herstellung von peptidamiden durch seitenkettenanknüpfung an einer festphase
DE602006011099D1 (de) Verfahren zur herstellung von peptidderivaten
DE60209458D1 (de) Verfahren zur Synthese von (2S,3aS,7aS)-1-(S)-Alanyl-octahydro-1H-2-carbonsäurederivaten und Verwendung in der Synthese von Perindopril
ATE425121T1 (de) Verfahren zur umwandlung von polysulfanen
DK1237847T3 (da) Fremgangsmåde til stereoselektiv syntese af cyckliske aminosyrer
DE50312796D1 (de) Verfahren zur herstellung von isocyanaten
EA200100213A1 (ru) Способ синтеза производных (1h)-бензо[c]хинолизин-3-онов
EP1336603A4 (de) Verfahren zur einführung von aminogruppen und verfahren zur synthese von aminosäuren
ATE451384T1 (de) Verfahren zur herstellung von peptiden
ATE387425T1 (de) Verfahren zur herstellung von bicalutamid
WO2003093301A3 (en) Process for the synthesis of peptides
DE50003759D1 (de) Verfahren zur herstellung von n-(4,5-bis-methansulfonyl-2-methyl-benzoyl)-guanidin, hydrochlorid
DE69829654D1 (de) Verfahren zur herstellung von rhizoferrin
DE60133395D1 (de) Verfahren zur herstellung von alpha'-chlorketonen
EP1063232A3 (de) Verfahren zur Herstellung von erythro 3-Amino-2-hydroxybuttersäurederivaten
DE602005024809D1 (de) Verfahren zur herstellung von gabapentin
ATE350388T1 (de) Verfahren zur herstellung von n-neohexyl-(a)- aspartyl-l-phenylalaninmethylester aus zwischenverbindungen die imidazolidin-4-on enthalten
DE602004021814D1 (de) Verfahren zur peptidsynthese
ATE417826T1 (de) Verfahren zur herstellung von zwischenprodukten
ATE342250T1 (de) Verfahren zur herstellung von (aminomethyl)trifluoromethylcarbinol-derivaten
ATE349545T1 (de) Enzymatisches verfahren zur herstellung von substituierter 2-amino-3-(2-amino-phenylsulfanyl)-propionsäure
DE69807527D1 (de) Verfahren zur herstellung von hochreinem tetranatriumsalz der ethylendiamintetraessigsäure
IT1295311B1 (it) Processo industriale per la sintesi di ammino acetileni
ATE365745T1 (de) Verfahren zur herstellung von perindopril unter verwendung von tetramethyluroniumsalzen als kopplungsreagenzien
DE60316973D1 (de) Verfahren zur synthese von peptiden, die mindestens ein glycinmolekül enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties